Opportunities and Challenges of Organic Synthesis in Drug Discovery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 3767
Special Issue Editors
Interests: organic synthesis; analytical chemistry; peptide chemistry; natural chemistry; medicinal chemistry; drug design; crystallography
Special Issue Information
Dear Colleagues,
Organic synthesis plays a major role in the process of drug discovery, starting from the identification and optimization of the lead molecule until it becomes a drug. Initially, compounds are synthesized and evaluated in vitro at very small scale (2–20 mg) to identify their potential as a lead molecule. Once promising biological activity is identified, these compounds are synthesized at higher scale (100–1000 mg) for their preclinical pharmacokinetic and pharmacodynamics evaluations. The required amount of compound continuously increases to fulfill further toxicity and safety studies. Moreover, clinical evaluation requires more than 1 kg of the drug-like compounds, involving the use of process development chemistry to design and facilitate the effective and safe synthesis of compounds at large scale. However, most of the clinically available drug molecules generally contain unprotected polar groups including amines and N-heterocycles, thereby imposing a major challenge in the process of synthesis and purification of those compounds. To overcome this significant challenge, researchers from both academia and the pharmaceutical industry are continuously putting their efforts in collaboration to design and develop innovative synthetic strategies to accommodate these functionalities. In this regard, growing advancement in in silico drug design processes are also focused on devising effective algorithms to predict and plan robust and reproducible reaction mechanisms. Thus, advancement in organic synthesis methodologies will have a profound impact not only in the process of drug discovery in the pursuit of development of various therapeutic agents, but also in the improvement of human health.
This Special Issue focuses on recent advances in the design of innovative strategies for organic synthesis in the pursuit of the development of therapeutically potential agents targeting specific enzymes, receptors or macromolecules of the body for the treatment of various diseases including central nervous system, cardiovascular, respiratory, and gastrointestinal systems etc. We welcome researchers to contribute original research papers, short communications, and review articles from the different fields of drug discovery, such as computer-aided drug design, the organic synthesis of novel compounds and their pharmacological studies, or rationally designed or repurposed compounds with improved pharmacokinetic and pharmacodynamics properties at the preclinical and/or clinical levels.
Dr. Katharigatta Narayanaswamy Venugopala
Dr. Pran Kishore Deb
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Dr. Katharigatta Narayanaswamy Venugopala
Dr. Pran Kishore Deb
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- organic synthesis
- analytical techniques
- drug discovery
- biologically active molecules
- computer-aided drug design
- artificial intelligence
- drug repurposing
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
